Milestone Venture

Milestone is an enterprise platform that helps organizations measure and optimize the impact of AI coding tools.

Venture Capital Active null, United States
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

Milestone is an Israeli startup that has developed an enterprise platform for measuring the adoption and impact of AI coding tools. The platform connects to the full chain of enterprise development and AI-based coding tools, tracking their usage and cross-referencing the data with metrics such as code quality, development speed, and long-term maintainability. This provides development leaders with a clear view of how AI is affecting real performance and helps companies turn AI adoption into measurable performance. Milestone's platform integrates four core data sources: the company's codebase, project management tools, team structures, and the AI coding tools in use, creating a "genAI data lake" for actionable insights.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is Milestone Venture's most notable exit?
Milestone Venture's most notable exit is Chemomab Therapeutics, which completed a reverse merger in March 2021 and is now publicly traded on NASDAQ.
Which sectors does Milestone Venture focus on for investments?
Milestone Venture shows a concentration in Health Tech & Life Sciences, with one of its portfolio companies, Chemomab Therapeutics, operating in this sector. They also have investments in Business Software.
What is the funding stage focus of Milestone Venture?
Milestone Venture has participated in various funding stages, including a B Round, a C Round, and Convertible Debt rounds.
When was Milestone Venture most active in making new investments?
Milestone Venture had investment activity in December 2017, April 2019, and December 2019, with one new portfolio company added in December 2017.
Can you name a key portfolio company for Milestone Venture?
A key portfolio company for Milestone Venture is Chemomab Therapeutics, which focuses on innovative treatments for fibro-inflammatory-related diseases.
What is Milestone Venture's investment range?
Milestone Venture's investment range is between $175K and $20M.